## Abstract Antiangiogenic therapy could destroy tumor vasculature and inhibit tumor growth. It might inhibit tumor growth significantly when used as a single treatment modality and its therapeutic benefit may even be greater when used in combination with established treatment modalities such as ra
β¦ LIBER β¦
Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis
β Scribed by Kumar, Pawan; Benedict, Ryan; Urzua, Fernando; Fischbach, Claudia; Mooney, David; Polverini, Peter
- Book ID
- 109885901
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 783 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0023-6837
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Combination of human plasminogen kringle
β
Guang-Hui Jin; Ding-Yuan Ma; Ning Wu; Faiz M.M.T Marikar; Shun-Zi Jin; Wei-Wei J
π
Article
π
2007
π
John Wiley and Sons
π
French
β 660 KB
Enhanced antitumor efficacy by blocking
β
Yu Wei Zhao; Lu Jin; Zhi Mian Li; Cheng Jian Zhao; Yu Quan Wei; Han Shuo Yang
π
Article
π
2011
π
John Wiley and Sons
π
English
β 606 KB
CD40-Targeted Recombinant Adenovirus Sig
β
Kim, Yun-Sun; Kim, Yeon-Jeong; Lee, Jung-Mi; Han, Seung-Hee; Ko, Hyun-Jeong; Par
π
Article
π
2010
π
Mary Ann Liebert
π
English
β 628 KB
Enhancement of the antitumor efficacy of
β
Yukishige Nishino; Martin R. Schneider; Horst Michna
π
Article
π
1994
π
Springer-Verlag
π
English
β 515 KB
Enhanced efficacy in anti-tumour activit
β
S.P. Zheng; S.J. Zheng; R.L. Wu; F.Y. Huang; L.M. Cao; C.L. Jiao
π
Article
π
2007
π
Elsevier Science
π
English
β 567 KB
Therapy-induced antitumor vaccination in
β
Enrica Balza; Barbara Carnemolla; Lorenzo Mortara; Patrizia Castellani; Debora S
π
Article
π
2009
π
John Wiley and Sons
π
French
β 768 KB
## Abstract L19βIL2 and L19TNFΞ± are fusion proteins composed of L19(scFv), specific for the angiogenesisβassociated EDβB containing fibronectin isoform and ILβ2 or TNFΞ±. Because of the tumor targeting properties of L19, ILβ2 and TNFΞ± concentrate at therapeutic doses at the tumor vascular level. To